Publications
28
Citations
345
Est. group size
—
Recurring co-author estimate
Active years
9
Publishing since 2018
Kara S. Orr conducts biomedical research focused on diabetes, particularly the biology of insulin-producing pancreatic beta cells and how they are damaged or protected. The work includes studying type 1 diabetes (an autoimmune form) using preclinical models and testing small-molecule drugs, as well as examining how obesity and diet affect blood sugar regulation.
Publication activity peaked around 2019 and has slowed in recent years, averaging under two papers per year over the last five years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- 25-OR: ADA Presidents' Select Abstract: Preclinical Evaluation of TYK2 Inhibitors in Type 1 Diabetes
Diabetes · 2023
- Preventing Post-Transplant Diabetes Mellitus Via Orchestration of the IL-33/ST2 Axis in Pancreatic Islets
Biology of Blood and Marrow Transplantation · 2020
- Small molecule inhibition of NOX-1 reduces diabetes conversion in NOD mice
Integrative Molecular Medicine · 2019
- Episodic β‐cell death and dedifferentiation during diet‐induced obesity and dysglycemia in male mice
The FASEB Journal · 2018
- Episodic β-cell death and dedifferentiation during diet-induced obesity and dysglycemia in male mice
PMC · 2018
- Diabetes×5
- bioRxiv (Cold Spring Harbor Laboratory)×5
- American Journal of Physiology-Endocrinology and Metabolism×3
- SSRN Electronic Journal×2
- PMC×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile